Larvol Delta - Annovis-Bio-Announces-FDA-Authorization-to-Proceed-with-Phase-23-Trial-for-Buntanetap-in-Alzheimer39s-Disease

Posiphen (buntanetap) - Annovis Bio

https://www.prnewswire.com/news-releases/annovis-bio-announces-fda-authorization-to-proceed-with-phase-23-trial-for-buntanetap-in-alzheimers-disease-301642292.html

Oct 6, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next